3f1o: Difference between revisions

No edit summary
No edit summary
Line 32: Line 32:
</div>
</div>
<div class="pdbe-citations 3f1o" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 3f1o" style="background-color:#fffaf0;"></div>
==See Also==
*[[Factor inhibiting HIF|Factor inhibiting HIF]]
== References ==
== References ==
<references/>
<references/>
Line 47: Line 44:
[[Category: Tomchick, D R]]
[[Category: Tomchick, D R]]
[[Category: Activator]]
[[Category: Activator]]
[[Category: Alternative splicing]]
[[Category: Angiogenesis]]
[[Category: Angiogenesis]]
[[Category: Congenital erythrocytosis]]
[[Category: Congenital erythrocytosis]]
Line 59: Line 57:
[[Category: Pas domain]]
[[Category: Pas domain]]
[[Category: Phosphoprotein]]
[[Category: Phosphoprotein]]
[[Category: Polymorphism]]
[[Category: Transcription]]
[[Category: Transcription]]
[[Category: Transcription regulation]]
[[Category: Transcription regulation]]
[[Category: Ubl conjugation]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA